{"word_count": 172, "character_count": 1164}
Auteur : Zoe Low, journaliste de South China Morning Post à Hong KongProduction :&#160;South China Morning Post, quotidien de langue anglaise publié à Hong Kong depuis 1903. Sa diffusion s’élève à 104 000 exemplaires. Il est publié par le groupe SCMP, propriété de du groupe Alibaba depuis 2015.Diffusion : site du journal&#160;South China Morning PostDate et Heure : 3 août 2020, 18:31- The team has developed a vaccine which stops a key part of the infection process by preventing the coronavirus from attaching to human cells- Johnson Lau of PolyU says residents of Hong Kong and Macau should be given priority when the vaccine hits market after successful trialsSource : Zoe Low, "Coronavirus: researchers from Hong Kong, Macau hope to start clinical trials of vaccine in months", South China Morning Post, 03/08/2020. URL : https://www.scmp.com/news/hong-kong/health-environment/article/3095849/coronavirus-researchers-hong-kong-macau-hope (consulté le 03/08/2020).Photo "à la une" : Researchers from Hong Kong and Macau have developed a vaccine which stops a key part of the infection process by preventing the coronavirus from attaching to human cells. © AP